Home
About Us
Conditions & Procedures
Conditions
Procedures
Faculty
Patient Resources
Research
News & Events
Make a Gift
A gift to the UCSF Department of Surgery can help physicians and scientist find treatments and cures for serious liver diseases such as hepatitis B & C, and liver cancer.
Philip Rosenthal, M.D.
Professor of Pediatrics and Surgery
Departments of Pediatrics and Surgery
Medical Director, Pediatric Liver Transplant Program
Director, Pediatric Hepatology
Contact Information
| Academic Office Room MU 415, Box 0136 University of California, San Francisco San Francisco, CA 94143-0136 (415) 476-5892 (415) 476-1343 Fax prosenth@peds.ucsf.edu | Pediatric Liver Transplant Program 400 Parnassus Ave., Sixth Floor San Francisco, CA 94143 Phone: (415) 476-5892 Pediatric Intestinal Rehabilitation and Transplantation Program 400 Parnassus Ave., 2nd Floor San Francisco, CA 94143 Phone: (877) 762-6935 |
BiographyEducation
- 1967-71 State Univ. of N.Y. at Albany, Albany, NY, B.S. Magna Cum Laude, Biology
- 1971-75 State Univ. of N.Y. Downstate Med. Ctr. Brooklyn, NY, M.D. Magna Cum Laude
Residencies
- 1975-76 Albert Einstein/Bronx Mun. Hosp., NY, Intern Pediatrics
- 1976-78 Albert Einstein/Bronx Mun. Hosp., NY, Resident Pediatrics
Fellowships
- 1978-81 University of California, San Francisco, Fellow Pediatric Gastroenterology
Board Certification
- American Board of Pediatrics, General Pediatrics
- American Board of Pediatrics, Subspeciality in Pediatric Gastroenterology
- American Board of Pediatrics, Certificate of Added Qualification in Transplant Hepatology
Program Affiliations
- Pediatric Intestinal Rehabilitation and Transplantation Program
- Pediatric Liver Transplant Program
- UCSF Helen Diller Family Comprehensive Cancer Center
- UCSF Liver Center
Clinical Expertise
- Acute Liver Failure
- Biliary Atresia
- Bioartificial Liver Support
- Choledochal Cyst
- Cirrhosis
- Hepatitis B
- Hepatitis C
- Hepatocellular Carcinoma (Liver Cancer)
- Live Donor Liver Transplantation
- Liver Transplantation
- Neonatal Hepatitis
Research Interests
- Bioartificial liver devices
- Genetics and immunology of biliary atresia
- Idiopathic neonatal hepatitis
- Pediatric Acute Liver Failure (PALF)
- Quality of life after liver transplants
Biography
Philip Rosenthal, M.D. is Professor of Pediatrics and Surgery in the Departments of Pediatrics and Surgery respectively, Medical Director of the Pediatric Liver Transplantation and Program Director, Pediatric Hepatology. Dr. Rosenthal graduated Magna Cum Laude from SUNY Downstate Medical Center, did his pediatrics residency at Albert Einstein/Bronx Municipal Hospital in New York, and was a Pediatric Gastroenterology Fellow at UCSF. He joined the UCSF faculty in 1995, moving from UCLA where he was a Professor of Pediatrics and Medical Director of the Pediatric Liver Transplantation at Cedars-Sinai Med. Center in Los Angeles.
A pediatric hepatologist at the UCSF Benioff Children's Hospital, Dr. Rosenthal is internationally renowned for the care of children with liver disease, including liver cancer, and those undergoing liver transplantation. In addition, Dr. Rosenthal has and currently serves as Principal Investigator on numerous clinical trials to improve the care of patients with pediatric liver disease.
Dr. Rosenthal has won numerous honors for his research including work on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary atresia and the quality of life after liver transplants in children. He is a consultant to organizations such as the American Liver Foundation, Parents of Kids with Infectious Diseases, Alagille Syndrome Alliance, Studies of Pediatric Liver Transplantation (SPLIT), Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH). He is also on editorial boards and a regular reviewer for leading professional journals.
Clinical Trials
Selected Publications
- Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, et al. Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C trial. Hepatology 47: 836-843, 2008.
- Gorden NT, Arts HH, Parisi MA, Coene KL, Letteboer SJ, van Beersum SE, Mans DA, Hikida A, Eckert AM, Knutzen D, Alswaid AF, et al. CC2D2A is mutated in Joubert Syndrome and interacts with the ciliopathy-associated basal body protein CEP290. Am. J. Hum. Genet. 83:559-571, 2008.
- Davis AR, Rosenthal P, Glidden D. Pediatric liver retransplantation: outcomes and a prognostic scoring tool. Liver Transplant 15: 199-207, 2009.
- Rodrigue JR, Balistreri W, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, et al. Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes. J Pediatr Gastroenterol Nutr 48: 341-347, 2009.
- Shiboski CH, Kawada P, Golinveaux M, Tornabene A, Krishnan S, Mathias R, Den Besten P, Rosenthal P. Oral disease burden and utilization of dental care patterns among pediatric solid organ transplant recipients. J. Public Health Dent. 69: 48-55, 2009.Shiboski CH, Krishnan S, Besten PD, Golinveaux M, Kawada P, Tornabene A,
In the News
Teen Liver Transplant Recipient Throws Opening Pitch
Division of Transplant Surgery - Aug 22, 2011"Alfonso Garcia, the son of a respiratory therapist at UCSF Medical Center, was a typical, healthy 15-year-old when he started feeling sick ─ feverish, anemic, fatigued and jaundiced. Alfonso learned he had Wilson's disease, a rare genetic disorder in which copper isn't properly eliminated from the body and damages the liver and nervous system. He and his family received a grave prognosis. He had just 48 hours to find a liver transplant or he might not survive. With the help of Philip Rosenthal, M.D., (left) a pediatric liver specialist, and Ryutaro Hirose, M.D. (right), an organ transplant surgeon, Alfonso received a successful, emergency liver transplant. The donor was another young man, a 22-year-old from Sacramento who had lost his life suddenly due to a sinus infection that had spread to his brain."
Father Saves Son by Donating Part of His Liver
Father Saves Son by Donating Part of His Liver - Oct 01, 2001UCSF Medical Center staff performed the biopsy and told us the next day that William had a condition called biliary atresia, which is the closure or absence of some or all of the major bile ducts. That evening William had surgery to assess the damage to his liver and to open bile ducts.
Later, during clinic visits with Dr. Phil Rosenthal (pictured left) and pediatric nurse practitioner and Liver Transplant Coordinator Chris Mudge, we learned about a relatively new procedure call a living related liver transplant. To us, this procedure offered the best hope.
